Cefaleia unilateral contínua por lúpus eritematoso sistêmico: relato de caso

Autores

DOI:

https://doi.org/10.48208/HeadacheMed.2024.9

Palavras-chave:

Headache, Unilateral cephalalgia, Systemic lupus erythematosus, Corticosteroid therapy , Inflammation

Resumo

Background
Hemicrania continua is a rare form of cephalalgia featuring a chronic and persistent headache in only one side of the head.
Objectives
In this report, we present a case of a patient with hemicrania continua and systemic lupus erythematosus (SLE).
Methods
We collected patient data through the electronic medical record. Afterward, we reviewed the literature regarding hemicrania continua and its pathophysiology and correlation with neurovascular alterations, inflammation, and SLE.
Results
A 42-year-old woman visited the emergency department due to worsening constant unilateral cephalalgia that had been present for the past 6 months. The patient reported a highly intense (10/10) headache in the entire left hemicrania that radiated to the left shoulder. During physical examination, she presented with nystagmus, vertigo, and aggravated cephalalgia associated to body movement and, despite having no optic nerve thickening. In addition, she had jaundice, tachycardia, and splenomegaly. Complimentary exams found deep anemia, depletion in complement system and anti-nuclear factors, suggesting a possible hemolytic anemia (AIHA) due to SLE. Treatment was initiated with hydrocortisone and prednisone, associated with amitriptyline, fluoxetine and diazepam, reaching full remission. These syndromes have aggravated each other, and possibly the explanation for the cephalalgia remission was the control of AIHA and SLE. It features a rare case in literature and thus warrants discussion.

Downloads

Não há dados estatísticos.

Biografia do Autor

Lucas Teixeira, Universidade Federal do Rio Grande do Sul

Undergraduate student at Medicine School, Universidade Federal do Rio Grande do Sul, Brazil.

Matheus Cruz, Adjunt Professor at Department of Internal Medicine, Hospital de Clínicas de Porto Alegre, Brazil.

Adjunt Professor at Medicine School, Universidade Federal do Rio Grande do Sul, Brazil.

Adjunt Professor at Department of Internal Medicine, Hospital de Clínicas de Porto Alegre, Brazil.

Referências

Schytz HW, Amin FM, Selb J, Boas DA. Non-invasive methods for measuring vascular changes in neurovascular

headaches. Journal of Cerebral Blood Flow & Metabolism. 2017;39(4):633-49.Doi 10.1177/0271678x17724138 DOI: https://doi.org/10.1177/0271678X17724138

Kursun O, Yemisci M, van den Maagdenberg AMJM, H. Migraine and neuroinflammation: the

inflammasome perspective. The Journal of Headache and Pain. 2021;22(1).Doi 10.1186/s10194-021-01271-1

Dodick DW. Migraine. The Lancet. 2018;391(10127):1315-30.Doi 10.1016/s0140-6736(18)30478-1 DOI: https://doi.org/10.1016/S0140-6736(18)30478-1

Kass J, Mizrahi E. Neurology Secrets: Sixth Edition2016.1-531 p.

Aringer M. EULAR/ACR classification criteria for SLE.Seminars in Arthritis and Rheumatism. 2019;49(3):S14-S7. Doi 10.1016/j.semarthrit.2019.09.009 DOI: https://doi.org/10.1016/j.semarthrit.2019.09.009

Calabrò RS, Casella C, Militi D, Raciti G, Raciti L.Chronic Migraine: A Narrative Review on the Use of Botulinum Toxin with Clinical Indications and FutureDirections. Journal of Integrative Neuroscience. 2022;21(5).Doi 10.31083/j.jin2105141 DOI: https://doi.org/10.31083/j.jin2105141

Trysberg E, Nylen K, Rosengren LE, Tarkowski A. Neuronal and astrocytic damage in systemic

lupus erythematosus patients with central nervous system involvement. Arthritis & Rheumatism. 2003;48(10):28817.Doi 10.1002/art.11279

Pietrobon D. Migraine: New Molecular Mechanisms. The Neuroscientist. 2016;11(4):373-86.Doi DOI: https://doi.org/10.1177/1073858405275554

1177/1073858405275554

9. Osorio-Toro LM, Quintana-Ospina JH, MeloBurbano LÁ, Ruiz-Jiménez PA, Daza-Arana JE, RivasTafurt GP, et al. Autoimmune Hemolytic Anemia Caused by Cold Agglutinin Antibodies in Systemic Lupus erythematosus—a Rare Association: Case Report. Journal of Blood Medicine. 2023;Volume 14:507-11.Doi 10.2147/jbm.S420937 DOI: https://doi.org/10.2147/JBM.S420937

Neuropsychiatric Manifestations in Systemic Lupus Erythematosus Patients at a Tertiary Hospital in Peru. European Journal of Rheumatology. 2023;10(4):143- DOI: https://doi.org/10.5152/eurjrheum.2023.22095

Doi 10.5152/eurjrheum.2023.22095

Vecchia D, Pietrobon D. Migraine: a disorder of brain excitatory–inhibitory balance? Trends in Neurosciences. 2012;35(8):507-20.Doi 10.1016/j.tins.2012.04.007 DOI: https://doi.org/10.1016/j.tins.2012.04.007

Downloads

Publicado

2024-03-28

Como Citar

1.
Teixeira L, Cruz M. Cefaleia unilateral contínua por lúpus eritematoso sistêmico: relato de caso. Headache Med [Internet]. 28º de março de 2024 [citado 25º de novembro de 2024];15(1):35-7. Disponível em: https://headachemedicine.com.br/index.php/hm/article/view/1031

Edição

Seção

Relato de caso